Related Experiment Video
Updated: Aug 20, 2026

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
Published on: June 17, 2025
Trans-omics integration underscores distinct roles of polyunsaturated phospholipids in bidirectional offspring birth
Jia Zheng1, Sin Man Lam2, Wei Ling Florence Lim3
1Department of Endocrinology, Peking University First Hospital, Beijing, 100034, China; Key Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Insights
Abnormal birth weights are linked to reduced cord blood polyunsaturated phospholipids (PUFA-PLs). These lipid changes result from assimilation or utilization issues, not maternal supply, impacting fetal development.
Area of Science:
- Perinatal Medicine
- Metabolomics
- Omics Integration
Background:
- Abnormal birth weights (low, normal, high) correlate with adverse pregnancy outcomes and future metabolic issues.
- Cord blood lipid profiles offer insights into fetal growth and development.
- Understanding lipid signatures associated with non-optimum birth weights is crucial for early intervention.
Purpose of the Study:
- To investigate cord blood lipidomes in infants with low, normal, and high birth weights.
- To identify core lipid signatures linked to non-optimum birth weights.
- To integrate omics data (placental proteome, maternal plasma lipidome, clinical phenome) for biological insights.
Main Methods:
- Quantitative lipidomics performed on cord blood samples from two independent cohorts (discovery and validation).
- Trans-omics data integration with placental proteomics, maternal plasma lipidomics, and clinical phenomics.
- Analysis focused on identifying lipid signatures associated with birth weight categories.
Main Results:
- Significant reductions in cord blood polyunsaturated phospholipids (PUFA-PLs) observed in low birth weight (LBW) infants, linked to placental vesicle trafficking.
- Altered neutrophil degranulation noted in high birth weight (HBW) infants.
- Cord blood PUFA-PL reductions in LBW were due to impeded assimilation, while in HBW, they were due to increased utilization, not maternal supply deficiency.
Conclusions:
- Findings reveal distinct lipidomic profiles associated with LBW and HBW.
- Impeded assimilation (LBW) and increased utilization (HBW) of PUFA-PLs are key mechanisms.
- These insights can inform lipid-targeted strategies to optimize fetal growth and clinical outcomes.
Background:
Abnormal birth weights are associated with adverse pregnancy outcomes and future metabolic consequences. We aimed to examine cord blood lipidomes from low, normal and high birth weight (LBW, NBW, HBW) infants to identify core lipid signatures associated with non-optimum birth weight, and to derive biological insights through trans-omics data integration with placental proteome, maternal plasma lipidome and clinical phenome.
Methods:
We conducted quantitative lipidomics of cord blood samples from two independent cohorts: a retrospective discovery cohort (n = 147) and a prospective validation cohort (n = 73). Integration with placental proteomics, maternal plasma lipidomics and clinical phenomics was conducted to elucidate potential biological implications.
Findings:
We identified substantial reductions in cord blood polyunsaturated phospholipids (PUFA-PLs) (FDR <0.05) associated with placental vesicle trafficking and formation in LBW, and altered neutrophil degranulation in HBW. Combinatorial analyses of paired maternal plasma and cord blood samples indicated that cord blood PUFA-PL reductions were not attributable to deficient maternal supply, but rather to impeded assimilation (LBW) and increased utilisation (HBW).
Interpretation:
Our findings provide biological insights that may inform targetable, lipid-oriented nutritional and/or pharmacological strategies to modulate foetal growth and development, with the goal of optimising clinical outcomes for both mother and child.
Funding:
This work was supported by the National Natural Science Foundation of China (82170854, 81870579, 81870545, 82571043, 2357308); National High Level Hospital Clinical Research Funding (2022-PUMCH-C-019); Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0530200 and 2024ZD0530204); Beijing Municipal Science & Technology Commission (Z201100005520011); Peking University Clinical Scientist Training Program (No. BMU2023PYJH022); Beijing Municipal Natural Science Foundation (7202163, 7184252).
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Membrane Fluidity
Polygenic Traits
Asymmetric Lipid Bilayer
Pleiotropy
